To share insights and knowledge about stability studies, Q1 Scientific is hosting its second annual Stability Studies conference on Wednesday 18th October 2023 at the Killashee Hotel, Kildare.
By attending the Q1 Scientific Stability Studies Conference, analytical and quality professionals can learn about the latest trends and best practices in stability studies and product development. This is an opportunity to network with peers and gain valuable insights that can help improve stability study processes.
What can I expect from Stability Studies 2023?
The Q1 Scientific Stability Studies Conference will bring together industry experts and thought leaders to share their insights on the latest trends and best practices in stability studies and product development. Attendees will learn about how to approach regulatory requirements, technological advances, and innovative approaches in stability studies. The conference will feature a mix of presentations and discussions, providing ample opportunities for attendees to network and learn from their peers.
Who is speaking at the Stability Studies conference?
The conference features a lineup of distinguished speakers, including leading experts in stability studies. Guest speakers covering a broad range of topics related to stability studies, include:
- Darryl Souness, Head of Analytical at Cambrex on ‘How stability testing impacts the development of drug products’
- Kate Coleman, Principal Consultant on ‘A practical approach to stability program compliance’
- Dr. Mark Powell, Director of MP Scientific on ‘Stability studies in support of pharmaceutical development’
- Dr. Niamh Mac Fhionnlaoich, Research Fellow at APC on ‘Revolutionising pharma: How AI will transform process development’
Dr. Mark Powell, Director at MP Scientific
Dr. Mark Powell is a Fellow of the Royal Society of Chemistry (RSC) with over thirty years’ experience as a Senior Analytical Chemist. Mark has served as both Honorary Secretary and Honorary Treasurer of the RSC’s Analytical Division and led a working group on continuing professional development until July 2016. He has worked at a senior level in a number of companies with responsibility for analytical development and equipment qualification. In 2010 Mark was appointed Scientific Manager of a UK-based pharmaceutical CRO, with responsibility for guiding the direction of drug development programmes as well as establishing collaborations with academia and instrument manufacturers.
In 2013, he set up his own company to provide training and consultancy services to the pharmaceutical industry. His consultancy work has involved, amongst other things, managing the analytical aspects of pharmaceutical development programmes and conducting data integrity audits.
He is in demand as a trainer in topics such as pharmaceutical development, chromatography, spectroscopy, dissolution testing, data integrity, control of impurities, technical writing, stability/stress studies and sample preparation.
Darryl Souness, Head of Analytical at Cambrex
Darryl Souness is Head of Analytical at Cambrex in Edinburgh, a leading contract development and manufacturing organisation that provides drug substance, drug product, and analytical services across the entire drug lifecycle. He has over 20 years of experience in analytical chemistry, with a focus on stability and lot release testing, solid state characterisation, method development and validation. He leads a team of highly skilled scientists who use state-of-the-art equipment and techniques to provide the data needed for early-phase drug development decisions.
Darryl joined Cambrex in 2019, after working as a Head of Analytical at Solid Form Solutions, a company that was acquired by Cambrex. He entered the industry in 1992, with 4 years in Inorganics and Solvent Reclamation Chemistry. Prior to joining Cambrex, Darryl worked for over 19 years in senior analytical roles with contract research organisations.
Kate Coleman, Principal Consultant
Kate has over 20 years of experience in the Pharmaceutical Industry across several platforms including Biologics, Sterile Fill Finish, Vaccines, and Oral Dose. Kate is a practicing Qualified Person, Principal Consultant, Lead Auditor and an SME in several areas including Quality Control and Stability.
Dr. Niamh Mac Fhionnlaoich, Research Fellow at APC
Dr. Niamh Mac Fhionnlaoich is a Research Fellow at APC where she promotes digital and machine learning solutions. Her work currently focuses on solubility prediction to facilitate solvent selection and accelerate pharmaceutical process development.
She holds a PhD in Chemical Engineering from University College London and a Bachelor of Engineering in Chemical and Bioprocess Engineering from University College Dublin.
Who is the Stability Studies conference aimed at?
This conference is aimed at:
- Stability Programme Managers and Staff
- Research & Product Development Scientists and Managers
- Analytical Chemists and Microbiologists
- QC/QA Professionals
- Qualified Persons (EU)
- Regulatory Affairs professionals
Why attend Stability Studies 2023?
Attending the Q1 Scientific Stability Studies Conference offers numerous benefits for analytical chemists and quality professionals in the pharmaceutical, medical device, and life science industries. Here are some of the key benefits:
- Expand professional knowledge and skills: By attending the conference, attendees have the opportunity to expand their professional knowledge and skills in the field of stability studies. They will gain valuable insights that can help them improve their stability study processes and advance their careers.
- Access to industry experts: The conference will feature a lineup of distinguished speakers, including leading experts in the field of stability studies. Attendees will have the opportunity to interact with these experts, ask questions, and gain valuable insights into the latest trends and best practices in stability studies.
- Discover innovative approaches: With the rapid pace of technological advancement, new innovative approaches to stability studies are being developed. The conference will provide attendees with an opportunity to learn about these approaches and how they can be applied in their own work.
- Network with peers: The conference will bring together a diverse group of analytical chemists and quality professionals working in the pharmaceutical, medical device, and life science industries. Attendees will have the opportunity to network with their peers, exchange ideas, and learn from each other’s experiences.
From gaining insights into regulatory requirements to discovering innovative approaches and expanding professional knowledge and skills, attendees will leave the conference better equipped to excel in their roles.
How can I register for the conference?
The Q1 Scientific Stability Studies Conference will take place at the Killashee Hotel, Naas on Wednesday 18th October 2023. The conference promises to be an informative and engaging event for all attendees, and we encourage you to register as soon as possible.
Join us at the Killashee Hotel, Naas on Wednesday 18th of October 2023 for your opportunity to gain valuable insights that can help improve stability study processes.
Register now: https://conference.q1scientific.com/